GSK tops Access to Medicine Index, to invest £100M for initiatives in low income countries

Nov. 16, 2022 4:52 AM ETGSK plc (GSK)JNJ, NVS, RHHBY, PFE, SNY, AZN, BAYRY, BAYZF, MKGAF, RHHBF, TAK, MKKGYBy: Ravikash, SA News Editor

GSK Consumer Healthcare office in Warren, NJ, USA.

JHVEPhoto

GSK (NYSE:GSK) ranked number 1 in the 2022 Access to Medicine Index (ATMI), a report carried out by a non-profit organization that ranks 20 of the world's largest pharmaceutical companies on progress to improve access in 108 lower income countries

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.